-
Lipidor Signs Agreement With CRO for Implementation of Phase III Clinical Study of Drug Candidate AKP-02 Against Psoriasis
prnasia
July 08, 2020
Lipidor AB (Nasdaq First North: LIPI) today announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical company with extensive CRO capacity, to conduct a Phase III study for Lipidor's drug candidate AKP-02. The study is expected to
-
CRO Industry Update
contractpharma
April 28, 2020
Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.
-
PHASTAR to Expand Asia Pac and U.S. Footprint
contractpharma
June 25, 2019
To open new offices in in Tokyo and the West Coast of North America.
-
Quanticate Expands Presence in North America with New Toronto Office
contractpharma
June 20, 2019
The expansion, resulting from continued success and a year of growth across its key strategic partnerships, including top five pharmaceutical companies.
-
Dr Vatsal Shah to lead Siro Clinpharm’s US operations
expressbpd
June 14, 2019
Dr Shah is currently the COO of Siro Clinpharm and will transition to the Global Chief Operating Officer’s role to lead this expansion
-
Frontage Holdings Completes IPO
contractpharma
June 10, 2019
Proceeds from the global offering will be used to further expand the company's product development services capacity and capabilities.
-
The role of an integrated LIMS solution on supporting data integrity in current good manufacturing practice (cGMP) environments
europeanpharmaceuticalreview
May 21, 2019
The role of an integrated LIMS solution on supporting data integrity in current good manufacturing practice (cGMP) environments.
-
TFS International to Strengthen Strategic Planning Capabilities with Citeline Deal
b3cnewswire
April 23, 2019
TFS International, a leading, mid-sized clinical Contract Research Organization (CRO) is dedicated to the innovative use of technology to advance clinical development.
-
George Clinical establishes new presence in Singapore
biospectrumasia
April 10, 2019
This move broadens the geographic footprint of George Clinical in the Asia-Pacific region
-
CRO Inks OmniComm EDC Agreement
contractpharma
March 19, 2019
Will use TrialMaster for future studies, including an upcoming Phase Ib study on behalf of a sponsor based in the UK.